Global Intravascular Ultrasound [IVUS] Devices Market By Product (Consoles, Accessories), By Modality (Virtual Histology IVUS, Imap IVUS, Integrated Backscatter IVUS), By Application (Coronary Diagnosis, Coronary Intervention, Coronary Research, Non-Coronary/Peripheral Applications), By Region, and Key Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2022-2032

IVUS is a non-invasive medical imaging technique used to diagnose and treat vascular diseases. IVUS uses ultrasound technology, which sends high-frequency sound waves through the body. Echoes are recorded by using a series of elements representing different time periods for an echo to return from a patient’s body or any obstructions along the way.

The echoes are then used to reconstruct a real-time image of the inside of the blood vessels, including any plaque buildup or blockages in these vessels. IVUS offers high resolution images that allow physicians to take measurements and perform procedures without making an incision in the skin through which they can see directly into a vessel.

Detailed Segmentation:

The global intravascular ultrasound devices market is segmented on the basis of product type, end-user, and region. A detailed segmental description is listed below:

Based on Product Type

• Consoles
• Accessories

Based on Modality:

• Virtual Histology IVUS
• Imap IVUS
• Integrated Backscatter IVUS

Based on Application:

• Coronary Diagnosis
• Coronary Intervention
• Coronary Research
• Non-Coronary/Peripheral Applications

Based on End User

• Hospitals
• Specialty Clinics
• Ambulatory Surgical Centers
• Diagnostic Laboratories
• Research Institutes

Based on Region

• North America
  • The US
  • Canada
  • Mexico
• Europe
  • Germany
  • The UK
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe
• Asia-Pacific
  • China
  • Japan
  • India
  • Korea
  • Rest of the Asia-Pacific
• South America
  • Brazil
  • Argentina
  • Rest of South America
• Middle East and Africa
  • GCC
  • Israel
  • South Africa
  • Rest of the MEA

Market Dynamics:

Drivers for the Global Intravascular Ultrasound [IVUS] Devices Market

Intravascular Ultrasound (IVUS) imaging has become a significant imaging modality for the efficient diagnosis and cure of cardiovascular ailments over the past ten years, empowered by innovative uses of piezoelectric transducer technology. Restrictions on the production and performance of identical piezoelectric transducers have also hampered the enhancement of IVUS for increasingly clinically meaningful uses, such as forward viewing matrices for leading interventions and high-resolution imaging of arterial structures such as vulnerable plaque and fibrous cap, as well as the application of techniques such as the harmonic image of tissue and contrast agents.

Micromachined Capacitive Ultrasonic Transducer (CMUT) technology demonstrates great potential to transform the IVUS not only to meet these clinical needs, but also to unlock the potential for low-cost imaging devices combined with therapeutic tools. Manufacturing techniques with a maximum process temperature of 250°C have been established to build CMUTs on the same silicon chip with combined electronic components. Using these techniques, the CMUT arrays were properly assembled to forward the IVUS display in the 10-20 MHz range.

These array elements were presented in terms of pulse-echo response, radiation pattern measurements, and showed their volumetric imaging potentialities at different imaging targets. Therefore, the increased application of Capacitive Micromachined Ultrasonic Transducer (CMUT) Technology is expected to fuel the economic growth of the intravascular ultrasound (IVUS) device market.

Restraints for the Global Intravascular Ultrasound [IVUS] Devices Market

The main limitations of intravascular ultrasound that is commonly used in a cardiac catheterization laboratory are its cost, the increase in the time of the technique, and the fact that it is considered an interventional technique and must be performed using angiography. In addition, there may be additional dangers imposed by the IVUS catheter application.

IVUS brings considerable additional exploration time and some elevated risks to the patient beyond the performance of a standard diagnostic angiographic examination. This reinforcement is considerably less when the IVUS is part of a percutaneous coronary intervention, since much of the setup is identical for the intervention and for IVUS imaging. These issues are slated to further hamper the revenue growth of the intravascular ultrasound device market.

Competitive Landscape:

• Axle International
• Boston Scientific Corporation
• Infraredx Inc.
• Koninklijke Philips N.V.
• Terumo Corporation
• Siemens Healthineers AG
• Conavi Medical Inc.
• ACIST Medical Systems
• Others

These key industry players are now focusing on mergers, partnerships, acquisitions, product developments, and collaboration strategies, in order to sustain their respective competitive edge.

For instance, In May, 2019, Koninklijke Philips N.V. launched the new IntraSight interventional applications platform. It enables systems to integrate physiology and intravascular imaging applications for image-guided procedures. This product launch enabled the company to expand its product portfolio and strengthen its position in the global intravascular ultrasound devices market.

Key Developments:

• In 2020, Hitachi Ltd. has launched ARIETTA 750. It offers advanced diagnostic performance and high image quality.
• In 2019, Philips has launched its new Intra Sight, which offers a comprehensive suite of clinically proven instant intravascular ultrasound modalities to simplify complex interventions and increases the flow of routine procedures.
• In September, 2021, Siemens Healthineers introduced Luminos Impulse, a fluoroscopy system with a novel design and characteristics shared by high-end fluoroscopy systems inclusive of a smooth imaging chain, exhaustive dose optimization, cybersecurity characteristics, and detector-sharing possibilities for radiography.
• In May, 2021, Siemens Healthineers introduced Somatom X.ceed, a novel high-resolution, high-speed CT (computed tomography) scanner engineered particularly for the most demanding clinical areas where time and accuracy are of the utmost significance.
• In January, 2021, Avinger Inc. declared complete commercial kick-off of its Tigereye™ image-guided Chronic Total Occlusion (CTO) crossing system. With the introduction of complete commercial kick-off, current and prospective accounts all through the U.S. and Germany are presently capable of placing orders for the Tigereye appliance. At the time of the final quarter of 2020, Avinger administered a restricted kick-off at 12 clinical centers in the U.S. and Germany

For the Intravascular Ultrasound [IVUS] Devices Market research study, the following years have been considered to estimate the market size: